Victoria Ozberk

Gold Coast, QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Subclinical exposure to Streptococcus pyogenes drives the development of long-lived homologous immunity.

Subclinical exposure to Streptococcus pyogenes drives the development of long-lived homologous immunity.

Journal: Nature communications

Published: July 17, 2025

A phase 1 randomized controlled trial of a peptide-based group A streptococcal vaccine in healthy volunteers.

A phase 1 randomized controlled trial of a peptide-based group A streptococcal vaccine in healthy volunteers.

Journal: Trials

Published: August 27, 2024

Disruption of IL-17-mediated immunosurveillance in the respiratory mucosa results in invasive Streptococcus pyogenes infection.

Disruption of IL-17-mediated immunosurveillance in the respiratory mucosa results in invasive Streptococcus pyogenes infection.

Journal: Frontiers in immunology

Published: December 07, 2023

Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus.

Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus.

Journal: NPJ vaccines

Published: February 12, 2023

Streptolysin O Deficiency in Streptococcus pyogenes M1T1 covR/S Mutant Strain Attenuates Virulence in In Vitro and In Vivo Infection Models.

Streptolysin O Deficiency in Streptococcus pyogenes M1T1 covR/S Mutant Strain Attenuates Virulence in In Vitro and In Vivo Infection Models.

Journal: mBio

Published: February 06, 2023

Chimeric hepatitis B surface antigen virus-like particles expressing the strep A epitope p*17 elicit a humoral immune response in mice.

Chimeric hepatitis B surface antigen virus-like particles expressing the strep A epitope p*17 elicit a humoral immune response in mice.

Journal: Heliyon

Published: November 04, 2022

Assembly of Immunogenic Protein Particles toward Advanced Synthetic Vaccines.

Assembly of Immunogenic Protein Particles toward Advanced Synthetic Vaccines.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: September 22, 2022

Pneumococcal Phasevarions Control Multiple Virulence Traits, Including Vaccine Candidate Expression.

Pneumococcal Phasevarions Control Multiple Virulence Traits, Including Vaccine Candidate Expression.

Journal: Microbiology spectrum

Published: May 10, 2022

Ambient Temperature Stable, Scalable COVID-19 Polymer Particle Vaccines Induce Protective Immunity.

Ambient Temperature Stable, Scalable COVID-19 Polymer Particle Vaccines Induce Protective Immunity.

Journal: Advanced healthcare materials

Published: October 08, 2021

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils.

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils.

Journal: Nature communications

Published: July 21, 2021

Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super-infection.

Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super-infection.

Journal: Clinical & translational immunology

Published: April 06, 2021

Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from covR/S Mutant Streptococcus pyogenes.

Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from covR/S Mutant Streptococcus pyogenes.

Journal: mBio

Published: February 24, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026